ORI.CN - Orion Nutraceuticals Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD

Orion Nutraceuticals Inc.

1055 West Hastings Street
Suite 300
Vancouver, BC V6E 2E9
Canada
604-609-6196
http://www.orionnutra.ca

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan FiteniCEO & Director130.34kN/AN/A
Mr. Christopher P. Cherry C.A., C.P.A., CPA, CA, CGACFO & Director90kN/A1979
Ms. Jan UrataCorp. Sec.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Orion Nutraceuticals Inc., a cannabis life science company, focuses on the production and distribution of medicinal and recreational cannabinoid oil and extracts for the sports medicine market in Canada. It focuses on growing cannabis and extracting cannabis oil for use as an ingredient in proprietary health and beauty products, as well as distributed in bulk to other manufacturers. Orion Nutraceuticals Inc. has various professional sports strategic alliances. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

Orion Nutraceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.